Page last updated: 2024-10-15
caloxin 2a1
Cross-References
| ID Source | ID |
|---|---|
| PubMed CID | 131852770 |
| MeSH ID | M0383393 |
Synonyms (4)
| Synonym |
|---|
| CS-0188741 |
| caloxin 2a1 |
| HY-P3278 |
| AKOS040758068 |
Research Excerpts
Overview
Caloxin 2A1 is a novel inhibitor of the plasma membrane (PM) Ca(2+)-pump.
| Excerpt | Reference |
|---|---|
| "Caloxin 2A1 is a novel inhibitor of the plasma membrane (PM) Ca(2+)-pump [Am. " | ( Mechanism of action of the novel plasma membrane Ca(2+)-pump inhibitor caloxin. Chaudhary, J; Grover, AK; Holmes, ME, 2003) |
| "Caloxin 2A1 is a peptide obtained by screening a random peptide phage display library for binding to the second extracellular domain (residues 401-413) sequence of PM Ca2+ pump isoform 1b." | ( Caloxin: a novel plasma membrane Ca2+ pump inhibitor. Chaudhary, J; Escher, E; Grover, AK; Matharu, J; Walia, M, 2001) |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (6)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 2 (28.57%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 5 (71.43%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||